DossierENTITY

Phase 3 trial failure

Coverage of Phase 3 trial failure in the Nexus archive.

Earliest in view: Jul 31 · 13:54 UTCMost recent: Jul 31 · 13:54 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 31 · 13:54 UTCMARKETWATCH
Novo Nordisk’s stock slumps after failed trial — adding to the company’s woes
Novo Nordisk's stock declined following the announcement of a failed Phase 3 trial. The Danish healthcare company faces added challenges due to the trial's unsuccessful outcome.